Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Exelixis and NBE-Therapeutics Enter Into Exclusive Collaboration and License Option Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer

Wednesday, September 09, 2020

Exelixis Incand NBETherapeutics announced a partnership to discover and develop multiple antibodydrug conjugates ADCs for oncology applications by leveraging NBEs unique expertise and proprietary platforms in ADC discovery including sitespecific conj...

AnGes and Brickell Biotech Announce a Collaboration Agreement for the Development of a Novel DNA Vaccine Candidate for COVID-19 in the U.S.

Wednesday, September 09, 2020

AnGes Inc announced a collaboration agreement with Brickell Biotech Inc Brickell a clinicalstage pharmaceutical company through which Brickell has the right to develop AnGes proprietary investigational adjuvanted plasmid DNA vaccine intended to prev...

AnHeart Licenses Two Clinical Stage Oncology Candidates from Daiichi Sankyo

Tuesday, September 08, 2020

AnHeart Therapeutics Co Ltd a clinical stage oncology company focused on underserved patients in global markets has through its subsidiary AnHeart Therapeutics Inc entered into license agreements with Daiichi Sankyo Company Limited Daiichi Sankyo TYO...

Aridis Announces Agreement with the FDA on Updated Phase 2 Clinical Trial Design for AR-501

Tuesday, September 08, 2020

Aridis Pharmaceuticals Inc a biopharmaceutical company focused on the discovery and development of novel antiinfective therapies to treat lifethreatening infections today announced it has reached an agreement with the US Food and Drug Administration...

Grifols to acquire Alkahest to enhance discovery research and development to identify innovative therapies

Monday, September 07, 2020

Grifols a leading global producer of plasmaderived medicines and a leader in the development of innovative diagnostic solutions today announced it has entered into a transaction to acquire the remaining equity of Alkahest Inc in exchange for a total...

Ehave Signs Licensing Agreement to Enhance its Telemedicine Platform

Saturday, September 05, 2020

Ehave Inc a provider of digital therapeutics delivering evidencebased therapeutic interventions to patients announced it is entering into a licensing agreement with a telemedicine solutions provider from a single integrated platform Under the terms...

Kite and HiFiBiO Therapeutics Partner to Discover Novel Targets and Antibodies Against Acute Myeloid Leukemia

Friday, September 04, 2020

Kite a Gilead Company and HiFiBiO Therapeutics announced the companies have entered into a twoyear research collaboration and license agreement in acute myeloid leukemia AML Through this collaboration HiFiBiO will use its proprietary technology platf...

PPD and Lupus Therapeutics Collaborate to Support Lupus Clinical Research

Friday, September 04, 2020

PPD Inc a leading global contract research organization and Lupus Therapeutics LT an affiliate of the Lupus Research Alliance known for its lupus clinical trials expertise have entered into a collaboration to expand and enhance lupus clinical researc...

Igyxos and Selexis Enter Service Agreement to Advance Igyxos’ First-In-Class Monoclonal Antibody for the Treatment of Human Infertility

Thursday, September 03, 2020

Selexis SA and Igyxos announced that they have entered into a service agreement to develop Igyxos firstinclass monoclonal antibody mAb drug candidate for the treatment of human infertility Under the agreement Igyxos will utilize Selexis proprietary S...

BiomX Enters Collaboration with Boehringer Ingelheim with the Goal of Discovering Microbiome-Based Biomarkers for Inflammatory Bowel Disease

Thursday, September 03, 2020

BiomX Inc a clinical stage company developing natural and engineered phage therapies that target specific pathogenic bacteria announced that it has entered into a collaboration with Boehringer Ingelheim to utilize the BiomX XMarker microbiomebased bi...